DS9

(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one

Created:	2019-08-23
Last modified:	2020-12-16

Find Related PDB Entry
2 entries where DS9 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	1
Bond Count	41
Aromatic Bond Count	10

2D diagram of DS9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one
Formula	C₁₆ H₁₅ F N₄ O
Molecular Weight	298.315
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	C[C]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45
SMILES	OpenEye OEToolkits	2.0.7	CC12CCCN1CC3=NNC(=O)c4cc(cc5c4c3c2[nH]5)F
Canonical SMILES	CACTVS	3.385	C[C@]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@]12CCCN1CC3=NNC(=O)c4cc(cc5c4c3c2[nH]5)F
InChI	InChI	1.03	InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1
InChIKey	InChI	1.03	DENYZIUJOTUUNY-MRXNPFEDSA-N

Drug Info: DrugBank

DrugBank ID	DB14769
Name	Pamiparib
Groups	investigational
Description	Pamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy).
Synonyms	Pamiparib
Categories	Antineoplastic Agents Antineoplastic and Immunomodulating Agents Enzyme Inhibitors Poly (ADP-ribose) polymerase (PARP) inhibitors Poly(ADP-ribose) Polymerase Inhibitors
ATC-Code	L01XK06
CAS number	1446261-44-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL4112930
PubChem	135565554
ChEMBL	CHEMBL4112930

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.